|
|
|
Insider
Information: |
Alles Mark J |
Relationship: |
Director |
City: |
Summit |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
18,761 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,356,420 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
18,761 |
|
|
Total
Value |
$1,356,420 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-13.3%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2023-09-16 |
3,666 |
2020-05-13 |
0 |
Premium* |
|
Turning Point Therapeutics, Inc. |
TPTX |
Director |
2022-08-17 |
0 |
2021-06-21 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-05-23 |
15,095 |
2022-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2018-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,500 |
187,627 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2018-05-04 |
4 |
D |
$86.89 |
$131,986 |
D/D |
(1,519) |
186,108 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2018-05-09 |
4 |
B |
$82.60 |
$99,784 |
D/D |
1,208 |
187,316 |
0.01 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2018-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,929 |
196,245 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2018-12-16 |
4 |
D |
$68.20 |
$264,343 |
D/D |
(3,876) |
192,369 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,809 |
226,178 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-03-01 |
4 |
D |
$85.96 |
$1,194,844 |
D/D |
(13,900) |
212,278 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-05-02 |
4 |
D |
$95.21 |
$630,290 |
D/D |
(6,620) |
221,266 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-05-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,608 |
227,886 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(366,495) |
0 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,252) |
0 |
0 |
- |
|
CELG |
Celgene Corp |
CEO, CHAIRMAN OF BOARD |
|
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
145,229 |
366,495 |
0 |
- |
|
CELG |
Celgene Corp |
Chief Commercial OfficerOffice |
|
2012-02-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,409 |
|
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2020-05-13 |
4 |
B |
$8.86 |
$88,590 |
D/D |
10,000 |
10,000 |
2.39 |
% |
|
TPTX |
Turning Point Therapeutic... |
Director |
|
2021-06-21 |
4 |
B |
$81.34 |
$162,680 |
D/D |
2,000 |
2,000 |
2.39 |
% |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
2,300 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,980 |
7,280 |
0 |
- |
|
TPTX |
Turning Point Therapeutic... |
Director |
|
2022-08-17 |
4 |
D |
$76.00 |
$152,000 |
D/D |
(2,000) |
0 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2022-10-31 |
4 |
B |
$86.75 |
$314,469 |
D/D |
3,625 |
10,905 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Director |
|
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
4,190 |
15,095 |
0 |
- |
|
SYRS |
Syros Pharmaceuticals, In... |
Director |
|
2023-09-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,666 |
3,666 |
0 |
- |
|
CELG |
Celgene Corp |
See Remarks |
|
2012-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,056 |
3,056 |
0 |
- |
|
CELG |
Celgene Corp |
See Remarks |
|
2012-04-14 |
4 |
D |
$78.32 |
$70,645 |
D/D |
(902) |
2,154 |
0 |
- |
|
CELG |
Celgene Corp |
See Remarks |
|
2013-04-13 |
4 |
D |
$123.00 |
$220,293 |
D/D |
(1,791) |
4,946 |
0 |
- |
|
CELG |
Celgene Corp |
See Remarks |
|
2013-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,583 |
6,737 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|